NIH-funded research U01 cooperative agreement

Identifying proteins linked to cognitive decline in Black and White adults

Official title: Proteomic biomarkers of incident cognitive impairment in Black and White adults

Funded at Univ of North Carolina Chapel Hill · NIH-11098546 · Data updated 2026-11-12

This study is looking at how inflammation and other factors might affect memory and thinking skills in Black and White adults, using blood samples to find proteins that could help us understand and prevent cognitive decline and dementia over time.

More Cognitive Impairment research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJune 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$727,319
NIH project number5U01AG082042-02
Project IDNIH-11098546 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include Black and White adults over the age of 21 who are at risk for cognitive impairment or dementia.

Less likely to help

Patients who are not part of the Black or White adult populations or those under 21 years old may not benefit from this research.

What this research studies

This research investigates the role of inflammation and other factors in the risk of cognitive impairment and dementia among Black and White adults. By analyzing blood samples from a large group of participants, the study aims to identify specific proteins that may be associated with cognitive decline. The research will utilize data from the REGARDS study, which includes a diverse population and extensive health information. Participants will be monitored over a period of more than 17 years to track changes in cognitive function and identify potential biomarkers for early intervention.

Why it matters

Potential benefit: If successful, this research could lead to the identification of biomarkers that help predict cognitive decline, allowing for earlier interventions and tailored treatments.

How similar studies have gone: Previous research has shown promise in identifying biomarkers related to cognitive decline, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Raffield, Laura M — Univ of North Carolina Chapel Hill
  • Study coordinator: Raffield, Laura M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.